DEERFIELD, Ill.--(BUSINESS WIRE)--
Baxter International Inc. (NYSE: BAX) will host an investor conference
on Monday, May 21, 2018 in New York City at the Pierre Hotel. The
investor conference will feature an innovation hall displaying product
and therapy advancements from Baxter’s pipeline beginning at 7:00 a.m.
EDT, and will again be available following the conclusion of the formal
presentations at 12:30 p.m. EDT. Presentations by members of the Baxter
management team will commence at 8:00 a.m. EDT.
The meeting and accompanying slides will be webcast live by Q4 Inc. and
will be accessible from Baxter’s corporate website at: www.baxter.com.
The meeting will be recorded by Baxter as copyrighted material and
cannot be recorded or rebroadcast without Baxter’s permission. To
register for the conference, please click on the following link: Event
Details & Registration.
About Baxter
Baxter provides a broad portfolio of essential healthcare products
across its portfolio, including acute and chronic dialysis therapies;
sterile IV solutions; infusion systems and devices; parenteral nutrition
therapies; inhaled anesthetics; generic injectable pharmaceuticals; and
surgical hemostat and sealant products. The company’s global footprint
and the critical nature of its products and services play a key role in
expanding access to healthcare in emerging and developed countries.
Baxter’s employees worldwide are building upon the company’s rich
heritage of medical breakthroughs to advance the next generation of
healthcare innovations that enable patient care.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180515006628/en/
Baxter International Inc.
Media Contact
Bill Rader,
(224) 948-5353
or
Investor Contact
Clare
Trachtman, (224) 948-3085
Source: Baxter International Inc.